secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARDELYX, INC. (ARDX)
CIK:        0001437402
Form:       8-K
Filed at:   2023-09-25T23:59:59+00:00
Accession:  0001628280-23-032952
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardelyx receives $30M milestone payments from Kyowa Kirin on Japan approval of tenapanor
--------------------------------------------------------------------------------

- Kyowa Kirin received MHLW approval in Japan for tenapanor for hyperphosphatemia in adult CKD patients on dialysis.
- Approval triggers $30M in milestone and amendment payments from Kyowa Kirin to Ardelyx.
- Ardelyx also receives $5M from HealthCare Royalty Partners under its existing agreement.
- Ardelyx may receive an additional $5M from HealthCare Royalty Partners if net sales in Japan exceed a target by 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1437402/000162828023032952/0001628280-23-032952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1437402/000162828023032952/ardx-20230925.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-032952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer